A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-EY-22-001 from the NIH Guide for Grants and Contracts. The overall purpose of this funding opportunity announcement (FOA) is to invite applicants from multidisciplinary research teams to develop a community-based resource of microbial data associated with the resident ocular microbiome of healthy individuals. Interests also exist in identifying factors microbial communities elaborate that impact human physiology. This announcement will support research projects designed to: delineate and characterize core ocular microbial constituents in the front of the eye; understand their immune and neuro int...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 6, 2022 Category: Research Source Type: funding
Maine Cancer Screening Grants
Grants for evidence-based interventions to increase the number of and/or improve the quality of cancer screening in Maine. Screenings include those for breast, cervical, colorectal, lung, prostate, and skin cancer. Rural populations are a priority. Geographic coverage: Maine -- Maine Cancer Foundation (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - March 11, 2022 Category: American Health Source Type: funding
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
Notice NOT-AR-22-012 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 28, 2021 Category: Research Source Type: funding
Feasibility Studies that Explore Healthy and Diseased Temporomandibular Joints (TMJ) using Single Cell Multi-Omic Analyses (UH2/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-22-005 from the NIH Guide for Grants and Contracts. The goal of this initiative is to encourage research focused on deciphering the cellular and molecular mechanisms underpinning temporomandibular joint disorders (TMJD) pain and tissue dysfunction using single-cell omics approaches. Delineation of cellular and molecular mechanisms that mediate TMJD resolution and homeostasis are also desired. Identification of cell populations and their effector pathways, in TMJD target tissue (e.g. synovial fluid, muscle, skin), as 1) molecular disease classifiers allowing for patient stratification, 2) diagn...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 12, 2021 Category: Research Source Type: funding
Notice of Correction of PAR-21-030, "Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)"
Notice NOT-AR-21-022 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 15, 2021 Category: Research Source Type: funding
Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Funding Opportunity PAS-21-245 from the NIH Guide for Grants and Contracts. Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial not allowed) (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2021 Category: Research Source Type: funding
Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional)
Funding Opportunity RFA-TR-21-009 from the NIH Guide for Grants and Contracts. This FOA is seeking applications for a portable sensing device to detect volatile organic compounds (VOCs, i.e. scents or odors) emanating from skin and to develop a catalog of VOCs as distinct signatures for at least 20 human diseases and conditions. These sensing devices must be able to associate VOC patterns using artificial intelligence to patients with various conditions for diagnostic purposes along with capabilities to incorporate and integrate vital signs. For VOC monitoring, these sensing devices can be Electronic-nose (E-nose) techn...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 3, 2021 Category: Research Source Type: funding
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
Notice NOT-AR-21-012 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 5, 2021 Category: Research Source Type: funding
Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad)
Notice NOT-OD-21-035 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 25, 2020 Category: Research Source Type: funding
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-053 from the NIH Guide for Grants and Contracts. Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 13, 2020 Category: Research Source Type: funding
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
Funding Opportunity PAR-21-045 from the NIH Guide for Grants and Contracts. Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 13, 2020 Category: Research Source Type: funding
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Funding Opportunity PAR-21-030 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that translate technology innovations from academic and other non-profit research sectors to the marketplace to advance the development of diagnostic and prevention tools or treatments for musculoskeletal, rheumatic or skin diseases. It supports pre-clinical research and development, such as moving products towards regulatory approval for clinical testing or making the new lab technologies more pra...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 8, 2020 Category: Research Source Type: funding
Institute and Center Award Rates and Funding Disparities
In 2011, Ginther et al. first demonstrated that African American and Black applicants to the National Institutes of Health received grant awards at a lower rate than their white counterparts (Ginther 2011). Since then, multiple studies have reproduced and extended this finding (Ginther 2011; Ginther 2016; Hoppe 2019; Erosheva 2020). Recently we reported that African American and Black (AAB) PIs are more likely to propose research on topics that are less likely to be funded (Hoppe 2019). We found that topic choice has little or no effect on whether an application is chosen for discussion, but after consideri...
Source: NIH Extramural Nexus - August 12, 2020 Category: Research Authors: Mike Lauer Tags: blog Open Mike Funding data Source Type: funding
NIAMS Rheumatic Diseases Research Resource-based Centers (P30- Clinical Trial Not Allowed)
Funding Opportunity RFA-AR-21-002 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 6, 2020 Category: Research Source Type: funding
NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed)
Funding Opportunity RFA-AR-21-004 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 10, 2020 Category: Research Source Type: funding
